Oropharyngeal Neoplasms: Clinical Trials

5 trials for Oropharyngeal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Active not recruiting 1, Recruiting 1, Unknown 1

Follow Oropharyngeal Neoplasms: new trials by email Literature Review of Oropharyngeal Neoplasms trials Research Report on Oropharyngeal Neoplasms

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
Electronic Health Record Review, Fentanyl, Laryngoscopy - Head and Neck Carcinoma, Hypopharyngeal Carcinoma
Phase 4RecruitingOHSU Knight Cancer Institute582026-09-222026-10-05
Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment
Gelclair Oral Mouth Rinse - Squamous Cell Carcinoma, Oropharyngeal Cancers
Phase 4Active not recruitingMcMaster University292025-12-152026-07-13
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer
Resection, Radiotherapy, Chemotherapy - Oropharyngeal Cancer
Phase 4UnknownUniversitätsklinikum Hamburg-Eppendorf2802018-01-052023-05-17
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
smoking cessation intervention, bupropion hydrochloride, gene expression analysis - Bladder Cancer, Cervical Cancer
Phase 4CompletedLisa Sanderson Cox, PhD5402007-12-012017-11-13
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
nicotine lozenge, nicotine patch - Bladder Cancer, Cervical Cancer
Phase 4CompletedFox Chase Cancer Center6422006-02-012016-03-29

Narrower conditions

Hypopharyngeal Neoplasms (4)  ·  Mouth Neoplasms (4)  ·  Head and Neck Neoplasms (3)  ·  Laryngeal Neoplasms (3)  ·  Nasopharyngeal Neoplasms (3)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Esophageal Neoplasms (2)  ·  Kidney Neoplasms (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Liver Neoplasms (2)  ·  Lung Neoplasms (2)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Otorhinolaryngologic Diseases (5)  ·  Otorhinolaryngologic Neoplasms (5)  ·  Pharyngeal Diseases (5)  ·  Pharyngeal Neoplasms (5)  ·  Stomatognathic Diseases (5)  ·  Mouth Diseases (4)  ·  Carcinoma (3)  ·  Laryngeal Diseases (3)  ·  Nasopharyngeal Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)

Interventions

Bupropion (1)  ·  Counseling (1)  ·  Drug Therapy (1)  ·  Early Intervention, Educational (1)  ·  Fentanyl (1)  ·  Gene Expression Profiling (1)  ·  Laryngoscopy (1)  ·  Methadone (1)  ·  Polymerase Chain Reaction (1)  ·  Psychiatric Rehabilitation (1)  ·  Radiotherapy (1)  ·  Surgical Procedures, Operative (1)  ·  Tobacco Use Cessation Devices (1)

Sponsors

Fox Chase Cancer Center (1)  ·  Lisa Sanderson Cox, PhD (1)  ·  McMaster University (1)  ·  OHSU Knight Cancer Institute (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)

Countries

United States (3)  ·  Canada (1)  ·  Germany (1)

Top investigators

Chia-Jung Busch, PD Dr. (1)  ·  Lisa S. Cox, PhD (1)  ·  Robert A. Schnoll, PhD (1)  ·  Ryan N Hellums (1)

Results publications

PMID 21266057, PMID 21775497, PMID 22241828, PMID 23733379, PMID 32727416, PMID 33300144, PMID 34611902, PMID 34791718, PMID 37230961, PMID 37650478, PMID 39868569

NIH funding

R01CA091912 (1)